[Form 4] Marvell Technology, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Christopher R. Koopmans, President and COO of Marvell Technology, Inc. (MRVL), purchased 6,800 shares of Marvell common stock on 09/25/2025 at a price of $78.03 per share. After the reported purchase, the filing shows beneficial ownership of 104,825 shares held indirectly through the Christopher R. Koopmans and Heather J. Koopmans Family Trust. The Form 4 notes the purchase was matchable under Section 16(b) but no profits were required to be disgorged. The filing was signed by an attorney-in-fact on behalf of Mr. Koopmans.

Positive

• Officer purchase disclosed: 6,800 shares acquired at $78.03 on 09/25/2025, showing insider buying activity
• Clear beneficial ownership disclosure: 104,825 shares held indirectly through the Christopher R. Koopmans and Heather J. Koopmans Family Trust
• Compliance note: Filing states the Section 16(b) matchable purchase resulted in no profits to disgorge, addressing potential short-swing profit concerns

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider acquisition of 6,800 shares at $78.03 increases officer's indirect stake modestly; routine disclosure with limited market impact.

The transaction is a straightforward open-market purchase by a senior executive, increasing indirect beneficial ownership to 104,825 shares via a family trust. The purchase size (6,800 shares) is small relative to Marvell's public float and therefore unlikely to materially affect valuation or operations. The Form 4's Section 16(b) note indicates a prior matchable transaction but explicitly states no profits to disgorge, removing a potential compliance concern.

Corporate Governance Expert

TL;DR: Properly executed Form 4 shows compliance with Section 16 reporting; indirect holdings held in family trust are disclosed.

The filing identifies the reporting person as both an officer and director and clearly discloses indirect ownership through a family trust, which is standard practice. The signature by an attorney-in-fact is noted and the filing includes the required explanatory remark about Section 16(b). There are no indications of irregularities, missed disclosures, or material governance issues in this short filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CA 95054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2025		P(1)		6,800	A	$78.03	104,825	I	By Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. While the Reporting Person's purchase of the Common Stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, there were no profits to disgorge.

2. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	09/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Christopher Koopmans (MRVL) report on the Form 4?

The Form 4 reports an open-market purchase of 6,800 shares of Marvell common stock on 09/25/2025 at a price of $78.03 per share.

How many Marvell shares does Christopher Koopmans beneficially own after this transaction?

Following the reported purchase, Mr. Koopmans beneficially owns 104,825 shares, held indirectly via the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Was this transaction subject to Section 16(b) short-swing rules?

The filing states the purchase was matchable under Section 16(b) but explicitly notes that there were no profits to disgorge.

What is the reporting person's role at Marvell?

The Form 4 identifies the reporting person as a Director and Officer with the title President and COO.

Who signed the Form 4 on behalf of Christopher Koopmans?

The Form 4 was signed by Christopher Koopmans by Blair Walters as Attorney-in-Fact on 09/25/2025.